The anti-cocaine vaccine, developed by researchers at the Federal University of Minas Gerais, Brazil, aims to produce antibodies that bind to cocaine when it is taken. This would make it harder for the substance to pass through the bloodstream to the brain. The vaccine would try to inhibit the brain reactions that trigger the craving.
Latest News
16:08
Moldova and the other candidate countries targeted for association with European cooperation against interference
16:06
PADROM warns about phishing attempts requesting personal data to verify the PAD policy
16:00
The Chamber of Deputies rejected an investigation into private flights to Mykonos and Nice
15:54
Kosovo's Foreign Minister, harsh reaction after the conviction of former UÇK leaders: “Terrible,” “unfair,” and “undeserved”
15:53
EU allocates 300 million euros for five major defense projects
See more news